BRIEF-Edgar Bronfman Raises Offer For National Amusements, Paramount Stake To $6 Billion

BRIEF-Edgar Bronfman Raises Offer For National Amusements, Paramount Stake To $6 Billion - WSJ

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Edgar Bronfman Raises Offer For National Amusements, Paramount Stake To $6 Billion - WSJ

Aug 25, 2024 4:13 AM

Aug 21 (Reuters) -

* EDGAR BRONFMAN RAISES OFFER FOR NATIONAL AMUSEMENTS,

PARAMOUNT

STAKE TO $6 BILLION- WSJ

Source text : https://tinyurl.com/2xlplqrc

Further company coverage:

Previous page： Sector Update: Consumer Next page： Rigel Pharmaceuticals Reports Initial Efficacy, Safety Data from Cancer Drug Study

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Sector Update: Consumer

Dec 9, 2024

01:28 PM EST, 12/09/2024 (MT Newswires) -- Consumer stocks were mixed Monday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) up 0.2% and the Consumer Discretionary Select Sector SPDR Fund (XLY) easing 0.1%. In corporate news, Mondelez International ( MDLZ ) is exploring an acquisition of Hershey (HSY) that would create a company with combined sales of nearly...

Rigel Pharmaceuticals Reports Initial Efficacy, Safety Data from Cancer Drug Study

Dec 9, 2024

01:32 PM EST, 12/09/2024 (MT Newswires) -- Rigel Pharmaceuticals ( RIGL ) said Monday R289 showed promising initial efficacy and safety data in its ongoing phase 1b study evaluating safety and tolerability in patients with relapsed or refractory lower-risk myelodysplastic syndrome. The drug candidate has demonstrated evidence of transfusion independence in elderly patients, Chief Medical Officer Lisa Rojkjaer said. The...

Newmont lays off nearly a dozen managers in restructuring move, Bloomberg News reports

Dec 9, 2024

Dec 9 (Reuters) - Gold miner Newmont ( NEM ) let go of nearly a dozen managers, including a member of its executive team, as part of a corporate overhaul, Bloomberg News reported on Monday, citing people familiar with the matter. ...

Poseida Therapeutics Says New Data Support Potential of Allogeneic Cell Therapy Platform

Dec 9, 2024

01:40 PM EST, 12/09/2024 (MT Newswires) -- Poseida Therapeutics ( PSTX ) said Monday it is presenting new data analysis of potential allogeneic cell therapy P-BCMA-ALLO1 in patients with relapsed/refractory multiple myeloma as well as new preclinical data supporting P-CD19CD20-ALLO1's anti-cancer profile. Interim clinical data from its phase 1 trial of P-BCMA-ALLO1 showed a 91% overall response rate in the...